Concepedia

Author

Mike Kirby

University of HertfordshireORCID

Also Known As

M G Kirby, M Kirby, M. G. Kirby, M. Kirby, M.G. Kirby, MIKE G. KIRBY, Maria Kirby, María Monserrate Briceño Kirby, Mike G Kirby, Mike G. Kirby

114

Publications

10.2K

Citations

18

H-Index

40

Concepts

All Affiliations

University of HertfordshireThe Prostate CentreRoyal Marsden NHS Foundation TrustUniversity College LondonPfizer (United States)
MK

About

Mike Kirby is an author at University of Hertfordshire specializing in urology, medicine, and sexual health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

194

2

Arts

1

1

14

3

Health Sciences

1

1

19

4

Nursing

1

1

14

5

Public Health

1

1

163

Mike Kirby

×

15

Publications

964

Citations

14

H-Index

YearCitations

Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus

Graham Jackson, Nicholas A. Boon, Ian Eardley,

International Journal of Clinical Practice

2010

245

IS ERECTILE DYSFUNCTION A MARKER FOR CARDIOVASCULAR DISEASE?

Mike Kirby, Graham Jackson, John Betteridge,

International Journal of Clinical Practice

2001

163

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality

Simon Anderson, David Hutchings, Mark Woodward,

Heart

2016

97

A SYSTEMATIC APPROACH TO ERECTILE DYSFUNCTION IN THE CARDIOVASCULAR PATIENT: A CONSENSUS STATEMENT

Graham Jackson, John Betteridge, Jason W. Dean,

International Journal of Clinical Practice

1999

88

Original Research—ED Pharmacotherapy: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors

Gabriel Schnetzler, Ian Banks, Mike Kirby,

The Journal of Sexual Medicine

2010

58

Development of <scp>UK</scp> guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer

Isabel White, James M. Wilson, Philippa Aslet,

International Journal of Clinical Practice

2014

58

Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice

Patrick Davey, Mike Kirby

World Journal of Urology

2020

52

BENIGN PROSTATIC HYPERPLASIA: COUNTING THE COST OF ITS MANAGEMENT

Roger Kirby, Mike Kirby, John M. Fitzpatrick

British Journal of Urology

2010

42

Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross‐sectional, <scp>UK</scp> epidemiological study

Julia DiBello, Christos V. Ioannou, Jonathan Rees,

British Journal of Urology

2015

37

Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice

Matthias Oelke, Maximilian Burger, David Castro‐Díaz,

British Journal of Urology

2011

31

Page 1